Evidence map›Paper›PMID 27286824›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Comparative genome-scale modelling of Staphylococcus aureus strains identifies strain-specific metabolic capabilities linked to pathogenicity.

Emanuele Bosi, Jonathan M Monk, Ramy K Aziz, Marco Fondi, Victor Nizet, Bernhard Ø Palsson

Abstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 153 papers.

0numbers the graph read from it
0cells of the map it votes in
153citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

153 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Multi-strain analysis ofmSystems · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Multi-strain Analysis ofbioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Yeast adapts to diverse ecological niches driven by genomics and metabolic reprogramming.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

93 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emanuele BosiDepartment of Biology, University of Florence, I-50019 Sesto Fiorentino, Italy;
Jonathan M MonkDepartment of Bioengineering, University of California, San Diego, La Jolla, CA 92093-0412;
Ramy K AzizDepartment of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, 11562 Cairo, Egypt;
Marco FondiDepartment of Biology, University of Florence, I-50019 Sesto Fiorentino, Italy;
Victor NizetDepartment of Pediatrics, University of California, San Diego, La Jolla, CA 92093-0760; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093-0760.
Bernhard Ø PalssonDepartment of Bioengineering, University of California, San Diego, La Jolla, CA 92093-0412; Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093-0760; palsson@ucsd.edu.

Funding

Systems Biology Approach to Redefine Susceptibility Testing and Treatment of MDR Pathogens in the Context of Host ImmunityU01AI124316 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PALSSON, BERNHARD O · 2016 to 2020
$10.2M
GENOMICALLY BASED MODELS FOR ANTIBIOTIC DEVELOPMENTR01GM057089 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PALSSON, BERNHARD O · 1998 to 2021
$6.9M
TRAINING & OUTREACH COREU54HD071600 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BEST, BROOKIE MANNING · 2011 to 2015
$3.6M
Model-guided Identification of Synthetic Lethal Genes for Drug Target DevelopmentR01GM098105 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PALSSON, BERNHARD O · 2011 to 2013
$1.8M
NIAID NIH HHS U01 AI124316NICHD NIH HHS U54 HD071600NIGMS NIH HHS R01 GM057089NIGMS NIH HHS R01 GM098105
6 · The paper itself

Abstract

Staphylococcus aureus is a preeminent bacterial pathogen capable of colonizing diverse ecological niches within its human host. We describe here the pangenome of S. aureus based on analysis of genome sequences from 64 strains of S. aureus spanning a range of ecological niches, host types, and antibiotic resistance profiles. Based on this set, S. aureus is expected to have an open pangenome composed of 7,411 genes and a core genome composed of 1,441 genes. Metabolism was highly conserved in this core genome; however, differences were identified in amino acid and nucleotide biosynthesis pathways between the strains. Genome-scale models (GEMs) of metabolism were constructed for the 64 strains of S. aureus These GEMs enabled a systems approach to characterizing the core metabolic and panmetabolic capabilities of the S. aureus species. All models were predicted to be auxotrophic for the vitamins niacin (vitamin B3) and thiamin (vitamin B1), whereas strain-specific auxotrophies were predicted for riboflavin (vitamin B2), guanosine, leucine, methionine, and cysteine, among others. GEMs were used to systematically analyze growth capabilities in more than 300 different growth-supporting environments. The results identified metabolic capabilities linked to pathogenic traits and virulence acquisitions. Such traits can be used to differentiate strains responsible for mild vs. severe infections and preference for hosts (e.g., animals vs. humans). Genome-scale analysis of multiple strains of a species can thus be used to identify metabolic determinants of virulence and increase our understanding of why certain strains of this deadly pathogen have spread rapidly throughout the world.

Indexed as

Genome, BacterialModels, MolecularSpecies SpecificityStaphylococcus aureusVirulence FactorsVirulence Factorscore genomemathematical modelingpangenomepathogenicitysystems biology

Identifiers

PMID27286824
PMCPMC4932939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.